Sean Mackay
CEO & Co Founder, Director
Diagnostic Platform
IsoPlexis
United States of America
Biography
Experienced entrepreneur passionate about applying life sciences and information technology to improve healthcare delivery. Co-founded and lead IsoPlexis, a venture-backed startup focused on accelerating the fight against cancer using our predictive patient profiling platform. Led company through foundational licensing with Yale and Caltech, venture capital financing, and building out our fantastic team while developing applications, products, and collaborations. Previously, helped incubate Kleiner Perkins-backed Lifesquare, which connected patients, payers, and providers through sharing essential healthcare information. At Lifesquare, generated business development and strategic initiatives related to partnerships across the healthcare ecosystem. Through work at Lazard and with several early-stage ventures, developed deep experience in structuring and financing life sciences and medical device and technology companies. Helped multiple public and private biotechnology and medical technology companies to manage times of strategic change. Experienced entrepreneur passionate about applying life sciences and information technology to improve healthcare delivery. Co-founded and lead IsoPlexis, a venture-backed startup focused on accelerating the fight against cancer using our predictive patient profiling platform. Led company through foundational licensing with Yale and Caltech, venture capital financing, and building out our fantastic team while developing applications, products, and collaborations. Previously, helped incubate Kleiner Perkins-backed Lifesquare, which connected patients, payers, and providers through sharing essential healthcare information. At Lifesquare, generated business development and strategic initiatives related to partnerships across the healthcare ecosystem. Through work at Lazard and with several early-stage ventures, developed deep experience in structuring and financing life sciences and medical device and technology companies. Helped multiple public and private biotechnology and medical technology companies to manage times of strategic change.
Research Interest
Accelerating the fight against cancer and a range of our toughest diseases by producing the world’s most precise detection systems